The Health Commissioner made a series of three killers!

On May 4th, the Health and Planning Commission website reported that on April 21, the Department of Pharmaceutical Affairs organized a symposium on the implementation of documents on the use of medicines in Beijing. The relevant responsible comrades from drug administration (arms) offices in all provinces (autonomous regions and municipalities) of the country participated.

The meeting pointed out that the implementation of Document No. 7 must focus on the linkage between procurement and use. It is necessary to do a good job of centralized procurement of medicines in the province as well as the rational use of medicines.

As a member of pharmaceutical companies engaged in drug administration, I believe that the information conveyed to the province's drug administration system and the industry is: the linkage between drug procurement and use. After the bidding, drug use management will also be put on the agenda.

Drug companies will not pass five barriers. Six will win the bids in various provinces. They will immediately receive quotas and purchase secondary bargaining fees. This is still not finished. Reasonable drug use and limited party management are waiting for them.

The price cuts for tenders and the power of the second bargaining have long been known to us, and the coming prescription restrictions will be another big “baking” test for the production companies.

Focus of discussion

Let's take a look at the specific content of the meeting.

The content of the report shows that there are two parts of the meeting. The first is the use and management of essential drugs.

“Regarding strengthening the management of the use of medicines, summing up the implementation of the basic medicine system, analyzing the current situation and tasks, exchanging the main experience and methods.... and further promoting the implementation of the basic medicine system for non-government organizations at the grass-roots level.”

The second is the management of the use of successful drugs.

“Interpretation of the key points and contents of the policy regarding the use of medicines, study and discussion on the promotion of centralized procurement of drug use management in public hospitals.”

Everyone agreed that implementing the No. 7 document must adhere to the basic principle of “four benefits” and focus on the linkage between procurement and use. We must adhere to the principle of “grasping both hands” and “both hands must be hard”. We must focus on the provincial focus. Purchasing, we must also pay attention to the rational use of drugs and reduce the burden of medication.

From the above statement, it can be seen that the future work priorities of the Health and Planning Commission will be changed from the previous ones to “centralized procurement” and “drug use”. The goal is to reduce the burden of medication.

We are already familiar with centralized purchasing. What are the new ways to use linkage?

Four strokes to grasp prescription management

Use management to focus on the following tasks:

The first is to make use of pharmacists' role of drug guidance and increase prescription reviews to penetrate the primary health care institutions and hospitals above Grade 2;

Second, the establishment of a doctor's appointment system requires local governments to strengthen research, actively explore ways of implementation, and organize implementation.

The third is to focus on tracking and monitoring auxiliary medications and drugs used in hospitals to reduce irrational use of drugs.

The fourth is to speed up the advancement of comprehensive clinical evaluation of medicines focusing on essential medicines.

From the perspective of the above-mentioned four measures, it is basically related to the “Guidance Opinion on Perfecting the Centralized Purchasing of Drugs in Public Hospitals” (Guobanfa [2015] No. 7 (hereinafter referred to as “Document 7 of the State Council”). Consistent. However, the State Council No. 7 document also mentioned the need to promote drug formulation, specifications, and packaging standardization. However, this part of the content should not be within the scope of the Health and Family Planning Commission.

Limited management era? !

For pharmaceutical companies, the four measures mentioned above will be the policies that affect the use of drugs (for pharmaceutical companies, it is sales).

Prescription reviews and doctor appointments are all deterrents. The effect is doctors prescribing prescriptions. However, deterrence is probably the most important to follow-up and monitor medicines used as auxiliary medications and hospitals. I am afraid there is no mention but can be expected to limit use.

In fact, this limited-party management is not new. In Shandong, Hebei, Henan, and other provinces and municipalities, medical institutions have long had the practice of limiting prescriptions and limiting the use of pre-drug drugs. This time from the level of the Department of Pharmacy of the National Health and Family Planning Commission to promote this work, the behavior of the limiting party is no longer the individual behavior of the hospital. It is an integrated system of assessment, reward and punishment that must be strictly enforced by the secondary and tertiary hospitals and primary medical institutions. Now.

The era of limited party management will come in an all-round way. The use of essential drugs at all levels of medical institutions (national drug bases, provincial supplements), use of drugs for record purchases, use of antibiotics and antibiotics, use of injections, prescription amount, etc. will all be affected. Limits to reduce the burden of medication.

Government charges show three killers

The information conveyed by the meeting to the province's drug administration system and the industry is that the State Department’s heavy documents should not be used as an empty talk. The provinces' response to documents cannot be merely on paper, but must be put into practice.

It is expected that most provinces in 2015 will advance the management of drug use in public hospitals. Try to really strictly manage the use of drugs, antibiotics, antibiotics are limited, Chinese medicine injections are limited, our vast number of pharmaceutical companies use reluctant price cuts in exchange for medical institutions promised purchases can still be guaranteed.

As a result, tendering, secondary bargaining, and prescription restrictions will become the three major killers for government drug control fees.